Donate

Report Back from SGO: What’s New in Ovarian Cancer Research?

Report Back from SGO: What’s New in Ovarian Cancer Research?

Are you curious about what’s new in ovarian cancer research? We invite you to join Dr. Premal Thaker, Distinguished Professor and interim Chief of Gynecologic Oncology at Siteman Cancer Center, to hear the latest updates from the Society of Gynecologic Oncology (SGO) Annual Meeting. Dr. Thaker will highlight what the research presented at the conference […]

SABCS Highlight Part II: Latest Ways to Think about Low-Risk DCIS

SABCS Highlight Part II

Join us for a discussion on the evolving understanding of Low-Risk DCIS and how these new insights can shape your care and decision-making. Our speakers will discuss the patient feedback from the COMET Study and its impact on others navigating similar choices. Plus, learn why donating biopsy tissue is vital for advancing discoveries that benefit […]

In a Nutshell: HIPEC and Ovarian Cancer

In a Nutshell HIPEC and Ovarian Cancer

Hyperthermic intraperitoneal chemotherapy (HIPEC), also known as “hot chemotherapy,” is a treatment for ovarian cancer, but it is controversial. In this brief conversation with Dr. Ernest Han, a gynecologic oncologist at City of Hope, we’ll discuss HIPEC, how it works, what the research says, and why there is a lack of consensus surrounding this treatment […]

Language Access: Understanding Your Rights

Language Access Understanding Your Rights

Getting a cancer diagnosis can be scary, especially if you don’t speak the same language as your healthcare team. But everyone deserves good care, and there are resources to help you understand your options in any language. Join us for a special talk about patient rights, language access, and how to speak up to make […]

SABCS Highlight: COMET Study Results on Monitoring Low-Risk DCIS

SABCS Highlight COMET Study Results on Monitoring Low Risk DCIS

Join us as Dr. Shelley Hwang (Principal Investigator) and Deborah Collyar (Patient Advocate) discuss the initial results from the low-risk DCIS study called Comparing an Operation to Monitoring, with or without Endocrine Therapy (COMET), which was presented at the San Antonio Breast Cancer Symposium in December 2024. Key Takeaways: At two years, women with low-risk […]

SABCS 2024 Roundup: What’s the Latest in Metastatic Breast Cancer (MBC)

SABCS 2024 Roundup What’s the Latest in Metastatic Breast Cancer (MBC)

Join us for a summary of the latest developments in MBC research presented at the annual San Antonio Breast Cancer Symposium (SABCS), 2024. Dr. Debu Tripathy, breast oncologist at The University of Texas MD Anderson Cancer Center, will break down the data, explain what it means, and answer questions. Key Takeaways from this Webinar: Ember-3 […]

What Clinical Trials Are Recruiting for Recurrent Ovarian Cancer?

clinical trials1

Clinical trials play an important role in the treatment of ovarian cancer, but finding ones that might be right for you can be difficult and time-consuming. In this webinar, Dr. Joshua Cohen, Medical Director of the Gynecologic Cancer Program at City of Hope Orange County, provides an overview of certain clinical trials currently (or about […]

Donate